MC

480.45

+2.26%↑

SANES

10.012

+2.38%↑

SAF

288.5

+0.35%↑

BBVA

19.3

+3.35%↑

BNP

84.93

+2.35%↑

MC

480.45

+2.26%↑

SANES

10.012

+2.38%↑

SAF

288.5

+0.35%↑

BBVA

19.3

+3.35%↑

BNP

84.93

+2.35%↑

MC

480.45

+2.26%↑

SANES

10.012

+2.38%↑

SAF

288.5

+0.35%↑

BBVA

19.3

+3.35%↑

BNP

84.93

+2.35%↑

MC

480.45

+2.26%↑

SANES

10.012

+2.38%↑

SAF

288.5

+0.35%↑

BBVA

19.3

+3.35%↑

BNP

84.93

+2.35%↑

MC

480.45

+2.26%↑

SANES

10.012

+2.38%↑

SAF

288.5

+0.35%↑

BBVA

19.3

+3.35%↑

BNP

84.93

+2.35%↑

Search

Metrovacesa SA

Open

BrancheFinanzen

11.8 1.29

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

11.66

Max

11.86

Schlüsselkennzahlen

By Trading Economics

Einkommen

-7.7M

Verkäufe

66M

KGV

Branchendurchschnitt

29.474

55.155

Gewinnspanne

-11.69

Angestellte

214

Dividenden

By Dow Jones

Nächstes Ergebnis

30. Apr. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.7B

Vorheriger Eröffnungskurs

10.51

Vorheriger Schlusskurs

11.8

Nachrichtenstimmung

By Acuity

9%

91%

8 / 440 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Metrovacesa SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Apr. 2026, 23:17 UTC

Ergebnisse

Samsung Forecasts Record First-Quarter Operating Profit

6. Apr. 2026, 23:00 UTC

Heiße Aktien

Stocks to Watch: Health Insurers, Mawson, Owlet

6. Apr. 2026, 22:13 UTC

Wichtige Markttreiber

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. Apr. 2026, 21:46 UTC

Akquisitionen, Fusionen, Übernahmen

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. Apr. 2026, 17:09 UTC

Wichtige Markttreiber

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. Apr. 2026, 16:56 UTC

Wichtige Nachrichtenereignisse

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. Apr. 2026, 14:47 UTC

Wichtige Markttreiber

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. Apr. 2026, 00:00 UTC

Wichtige Nachrichtenereignisse

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. Apr. 2026, 23:58 UTC

Market Talk
Wichtige Nachrichtenereignisse

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. Apr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. Apr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. Apr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. Apr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. Apr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. Apr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. Apr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. Apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. Apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. Apr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. Apr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. Apr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. Apr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. Apr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. Apr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. Apr. 2026, 18:36 UTC

Akquisitionen, Fusionen, Übernahmen

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. Apr. 2026, 17:59 UTC

Market Talk
Wichtige Nachrichtenereignisse

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. Apr. 2026, 17:13 UTC

Akquisitionen, Fusionen, Übernahmen

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. Apr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. Apr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Apr. 2026, 14:59 UTC

Ergebnisse

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Peer-Vergleich

Kursveränderung

Metrovacesa SA Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

11.45 / 11.7Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Weak Bullish Evidence

Stimmung

By Acuity

8 / 440 Ranking in Finanzen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Metrovacesa SA

Metrovacesa S.A. operates as a real estate development company in Spain. The company develops and sells residential and commercial premises, as well as sells land. Metrovacesa S.A. was founded in 1918 and is based in Madrid, Spain.
help-icon Live chat